Thimerosal Does Not Cause Autism: What the Evidence Actually Shows

The claim is that thimerosal, a mercury-based preservative once used in childhood vaccines, causes autism. The verdict is false. This is not a close call or an unsettled debate — it is one of the most thoroughly investigated questions in modern vaccine safety research, and the evidence consistently points in one direction.

The most concrete refutation is a natural experiment that history handed us. The FDA notes that thimerosal was removed or reduced to trace amounts in all routine childhood vaccines by 2001. If thimerosal caused autism, removal should have bent the curve downward. Instead, according to CDC ADDM Network data, autism prevalence rose from roughly 6.7 per 1,000 children in 2000 to 18.5 per 1,000 by 2016 — a near-tripling after the preservative was gone. Stehr-Green et al., published in the American Journal of Preventive Medicine in 2003, found the same pattern independently in California, Sweden, and Denmark: autism rates climbed after thimerosal was removed. A hypothesis that predicts a drop and observes a sustained rise is falsified, not merely weakened.

The epidemiological record is equally unambiguous. Madsen et al., publishing in the New England Journal of Medicine in 2002, tracked 530,000 Danish children and found no difference in autism rates between those who received thimerosal-containing vaccines and those who did not — a relative risk of 0.85 with a confidence interval of 0.60 to 1.20, meaning the data are statistically consistent with zero effect. A CDC Vaccine Safety Datalink study by Verstraeten et al., published in Pediatrics in 2003, examined 124,170 children and found no consistent statistically significant association between thimerosal exposure and any neurodevelopmental outcome, including autism. The 2020 Cochrane Collaboration systematic review, covering over 1.2 million children, found no credible evidence of a link and rated the evidence quality as moderate to high. The Institute of Medicine reviewed the full body of epidemiological and biological evidence in 2004 and concluded it favors rejection of a causal relationship.

The strongest version of the claim deserves a direct answer. It holds that ethylmercury — the form in thimerosal — accumulates in the developing brain and causes neurological damage. This is the methylmercury argument applied to the wrong compound. Toxicokinetic research establishes that ethylmercury is cleared from the body far more rapidly than methylmercury and does not accumulate to neurotoxic levels at vaccine doses. The biological mechanism the claim depends on does not operate the way proponents assert.

There is one thing genuinely worth conceding: the timing of routine childhood vaccination and the typical age at which autism symptoms become recognizable overlap closely. Parents who notice changes around the same time as a vaccine appointment are not being irrational — they are observing a real temporal coincidence. That coincidence, however, is not causation, and the studies above were specifically designed to test whether the association holds up when you control for it. It does not.

The manipulation pattern here is cherry-picking timing over population data. Proponents point to individual cases and the vaccination schedule's overlap with symptom onset, while ignoring the denominator: millions of children studied across multiple countries, a preservative removed for over two decades with no corresponding drop in autism rates, and a scientific consensus spanning the IOM, CDC, WHO, and Cochrane Collaboration. When you see a dramatic personal story paired with a refusal to engage with population-level data, that is the tell. Ask for the comparison group and the trend line after the intervention was removed.